Skip to content
EDITORS' CHOICE
SBIR reauthorization, a top BIO priority, is passed by Congress
Reauthorization of federal seed funding, a top priority for BIO’s work with Congress, passed the House with hefty bipartisan support on March 17 and is ...
Read More
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
BIO on the American Road in Puerto Rico: ‘Medicine Cabinet’ ready to reshore
Known as “America’s Medicine Cabinet,” Puerto Rico is working to maintain its leadership in U.S. biotech production by becoming a ...
Read More
International
Bio's View
Poll: U.S. voters want PBM and insurance reform—and strong biotech
Voters see a better path than Most Favored Nation to ensure access and affordability of innovative medicines Eight in 10 ...
Read More
